Back

Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Innovative strategies in percutaneous coronary intervention Revascularisation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ruben Tijssen

St Antonius Hospital, Nieuwegein (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Clinical impact of residual SYNTAX score after physiology guided state-of-art PCI in 3VD: insight from the SYNTAX II trial
Doctor N. Kogame (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Mechanism and impact of lesion morphology on the late lumen loss of drug-eluting resorbable magnesium scaffolds: a serial optical coherence tomography study
Doctor Y. Ueki (Matsumoto, JP)
Abstract Slides Video
Presentation thumbnail
Effects of scoring or cutting balloon use on severely calcified lesions treated by percutaneous coronary intervention
Doctor A. Ikuta (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Impact of intimal tracking for recanalization of CTO lesions on long-term clinical outcomes
Doctor S. Kano (Toyohashi, JP)
Abstract Slides Video
Presentation thumbnail
Incidence and outcomes of bailout stenting following use of drug coated balloon
Doctor H. Salim (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Innovative strategies in percutaneous coronary intervention

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources